Thus, we performed targeted molecular docking of PTAFR with several drugs commonly used in clinical and scientific research for AD treatment, including donepezil, memantine, EGCG, curcumin, and Huperzine A. The molecular docking was performed using the MOE software. This evidence concerns the gene PTAFR and Alzheimer disease.